Ipneb 250mcg/ml is primarily indicated in conditions like Asthma, Bronchospasm prophylaxis, Chronic obstructive pulmonary disease, Reversible airways obstruction, Rhinorrhea, and can also be given in adjunctive therapy as an alternative drug of choice in Rapid reversion to sinus ryhthm.
Ipneb 250mcg/ml is contraindicated in conditions like Glucoma, prostatic hypertrophy, Hypersensitivity,Urinary retention, Bladder obstruction.
The severe or irreversible adverse effects of Ipneb 250mcg/ml, which give rise to further complications include Tachycardia, Palpitation, Angina, Tremors, Arrythmia, Tachycardia. The signs and symptoms that are produced after the acute overdosage of Ipneb 250mcg/ml include Palpitations, Increased heart rate. The symptomatic adverse reactions produced by Ipneb 250mcg/ml are more or less tolerable and if they become severe, they can be treated Symptomatically, these include Dizziness, Headache, Constipation, Dry mouth, Blurred vision, Rashes, Urticaria, Dyspepsia, Nausea and vomiting, Nasal congestion, Backache, Nasal irritation, Urinary RetentionX, Urinary retention, Dry mouth, dizziness, dyspepsia, Anaphylaxia.
Ipratropium should be used with caution in patients with medical history especially of glaucoma, prostate trouble or any allergy especially to atropine or other belladonna derivatives. It should be used with caution during pregnancy.